BiotechTube
Discover
News
Company
Sign in
BiotechTube
Home
/
Avenna
/
Nina Skorytchenko
NS
Nina Skorytchenko
Chief Executive Officer
Avenna
Therapeutic Areas
Inflammatory Bowel Disease (IBD)
Rheumatoid Arthritis (RA)
Chronic Inflammatory Diseases
Avenna Pipeline
Drug
Indication
Phase
GlyHealth Biomarkers
Inflammatory Bowel Disease (IBD)
Pre-clinical/Validation
Leadership Team at Avenna
DD
Dr. Daryl Fernandes
Chief Science Officer
CW
Cindy Weiss
Project Manager
View full Avenna profile